Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
commonly used off-label for weight loss Mounjaro (tirzepatide) approved for Type 2 diabetes
Abstract Whilst the prevalence of obesity continues to increase at an alarming rate worldwide, the personal and economic burden of obesity-related complications becomes ever more important
Heres how the oral vs injectable options break down: Injectable The most effective drugs (measured by weight loss in clinical trials) are weekly injections, including Wegovy, Ozempic, Mounjaro, and Zepbound
Your BHRC physician will recommend the right choice based on your specific situation
Tirzepatide (Mounjaro) : A dual-action medication that targets both GLP-1 and GIP receptors, demonstrating remarkable results in weight loss and glucose control
Canada as a template for developed countries
US$ 27.41
US$ 25.82
US$ 22.16
US$ 27.09
